
BCTILs
Breast Cancer TILs scoring
About
This app offers pathologists and trainees a structured reference for scoring Tumour-Infiltrating Lymphocytes (TILs) in breast cancer histopathology. It features curated example images, common pitfalls, and reference guidance aligned with international recommendations to support consistent and standardized scoring.
What's New in BCTILs
1.0.24
September 30, 2026
- New icon - Fixed tab font contrast - Fixed grammar and typos
MoreFAQ
What is BCTILs used for?
BCTILs is a reference tool designed for pathologists and trainees to assist in scoring Tumour-Infiltrating Lymphocytes (TILs) in breast cancer histopathology. It provides visual examples and guidance to ensure consistent and standardized scoring.
Is BCTILs a diagnostic device?
No, BCTILs is explicitly stated as not being a diagnostic device. It serves as an educational and reference aid and does not replace clinical judgment or established laboratory protocols.
What kind of images does BCTILs provide?
BCTILs features curated example slide images that span the entire scoring range for TILs, from 5% to 100%. These images are designed to help users calibrate their scoring.
Does BCTILs help identify common mistakes?
Yes, the app includes information on common pitfalls and sources of misinterpretation that can occur at each score level. This feature aims to improve the accuracy of TILs assessment.
What breast cancer subtypes does BCTILs focus on?
TILs assessment is particularly important for triple-negative and HER2-positive subtypes of breast cancer. BCTILs supports the consistent scoring of TILs in these specific types.
How often is BCTILs updated?
The latest version of BCTILs is 1.0.23, which was last updated on September 24, 2026. The app was initially released on September 21, 2026.
What devices support BCTILs?
BCTILs is available for iPhone, iPad, and iPod devices. It is rated for ages 4 and up.
Does BCTILs have ads?
No, BCTILs does not contain advertisements. The app is free to download and use without any ad interruptions.


